997P Ongoing phase I trial results of AMT-253, a first-in-class MUC18-targeting antibody-drug conjugate in patients with melanoma and other advanced solid tumors.
Saved in:
| Title: | 997P Ongoing phase I trial results of AMT-253, a first-in-class MUC18-targeting antibody-drug conjugate in patients with melanoma and other advanced solid tumors. |
|---|---|
| Authors: | Guo, J.1 (AUTHOR), Cui, C.1 (AUTHOR), Kelly, R.2 (AUTHOR), Gao, B.3 (AUTHOR), Kwatra, V.4 (AUTHOR), Chen, Y.5 (AUTHOR), Richardson, G.6 (AUTHOR), Coward, J.I.7 (AUTHOR), Sabanathan, D.8 (AUTHOR), Jiang, Y.9 (AUTHOR), Wu, D.10 (AUTHOR), li, K.11 (AUTHOR), Sutherland, S.12 (AUTHOR), Abbas, N.13 (AUTHOR), Wang, S.14 (AUTHOR), Liang, X.15 (AUTHOR), Liu, X.16 (AUTHOR), Zhang, B.17 (AUTHOR), Liu, S-H.18 (AUTHOR), Meng, X.17 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS651-S652. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419379 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 997P Ongoing phase I trial results of AMT-253, a first-in-class MUC18-targeting antibody-drug conjugate in patients with melanoma and other advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Guo%2C+J%2E%22">Guo, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cui%2C+C%2E%22">Cui, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kelly%2C+R%2E%22">Kelly, R.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+B%2E%22">Gao, B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kwatra%2C+V%2E%22">Kwatra, V.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Y%2E%22">Chen, Y.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Richardson%2C+G%2E%22">Richardson, G.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Coward%2C+J%2EI%2E%22">Coward, J.I.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sabanathan%2C+D%2E%22">Sabanathan, D.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Y%2E%22">Jiang, Y.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+D%2E%22">Wu, D.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22li%2C+K%2E%22">li, K.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sutherland%2C+S%2E%22">Sutherland, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abbas%2C+N%2E%22">Abbas, N.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+S%2E%22">Wang, S.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+X%2E%22">Liang, X.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+X%2E%22">Liu, X.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+B%2E%22">Zhang, B.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+S-H%2E%22">Liu, S-H.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meng%2C+X%2E%22">Meng, X.</searchLink><relatesTo>17</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS651-S652. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419379 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.1566 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S651 Titles: – TitleFull: 997P Ongoing phase I trial results of AMT-253, a first-in-class MUC18-targeting antibody-drug conjugate in patients with melanoma and other advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guo, J. – PersonEntity: Name: NameFull: Cui, C. – PersonEntity: Name: NameFull: Kelly, R. – PersonEntity: Name: NameFull: Gao, B. – PersonEntity: Name: NameFull: Kwatra, V. – PersonEntity: Name: NameFull: Chen, Y. – PersonEntity: Name: NameFull: Richardson, G. – PersonEntity: Name: NameFull: Coward, J.I. – PersonEntity: Name: NameFull: Sabanathan, D. – PersonEntity: Name: NameFull: Jiang, Y. – PersonEntity: Name: NameFull: Wu, D. – PersonEntity: Name: NameFull: li, K. – PersonEntity: Name: NameFull: Sutherland, S. – PersonEntity: Name: NameFull: Abbas, N. – PersonEntity: Name: NameFull: Wang, S. – PersonEntity: Name: NameFull: Liang, X. – PersonEntity: Name: NameFull: Liu, X. – PersonEntity: Name: NameFull: Zhang, B. – PersonEntity: Name: NameFull: Liu, S-H. – PersonEntity: Name: NameFull: Meng, X. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
